Send to

Choose Destination
See comment in PubMed Commons below
ISRN Pharmacol. 2011;2011:480291. doi: 10.5402/2011/480291. Epub 2011 May 17.

Efficacy and Safety of COX-2 Inhibitors in the Clinical Management of Arthritis: Mini Review.

Author information

Medical Writing Group, Accenture Pharmaceutical Services, Karnataka, Bangalore 560072, India.


In the clinical management of arthritis, the choice of nonsteroidal anti inflammatory drug (NSAID) remains confusing and controversial. A common practice on the choice of NSAID in clinical management of arthritis is the risk benefit ratio. The main objective of this review is to addresses the main arguments for the pharmacological and clinical use of COX-2 inhibitors in relation to nonselective NSAIDs for the clinical management of arthritis. This review concluded that, both NSAIDs and COX-2 inhibitors are equally effective and are associated with increased risk of GI, renal, and CV, adverse effects. Complete understanding of the patient's comorbid conditions and concomitant medications, coupled with precise monitoring during the treatment, may help to decrease the threat of adverse effects induced by nonselective NSAIDs and selective COX-2 inhibitors.

PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center